In an article published in Genomic Psychiatry, researchers from Fudan University and Shanghai University of Traditional ...

In a comprehensive Genomic Press perspective article published today, researchers from Fudan University and Shanghai ...

Theravance Biopharma, Inc. ("Theravance Biopharma" or the "Company") (NASDAQ: TBPH) today announced that analyses of the initial Phase 3 program of ampreloxetine (Studies 169 and 170) will be ...

Early CPAP treatment for individuals with OSA may help reduce the onset of Parkinson disease and other neurodegenerative ...

Researchers from Aarhus University and Synuca Therapeutics recently presented a novel drug-like small-molecule inhibitor of sarco/endoplasmic reticulum calcium ATPase (SERCA), SYN-4569, with superior ...

disordered regions that extend from the fibril core—in prion-like pathological transmission in synucleinopathies. Their work is published in Neuron. The researchers first conducted serial ...

Accumulation of misfolded and insoluble α-Syn causes neuronal toxicity in preclinical models and has been identified as the underlying cause of synucleinopathies.

In previous studies, researchers have found an association between OSA and various synucleinopathies, however, no studies have confirmed causal links between OSA and PD. To determine whether OSA ...